All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AstraZeneca Plc, the most common co-covered peer. Source depth averages 2 original sources per story, versus 12.7 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dimensional Fund Advisors LP
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AstraZeneca Plc, the most common co-covered peer. Source depth averages 2 original sources per story, versus 12.7 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 6.6. Dimensional Fund Advisors LP appears in 1 tracked Healthcare story from June 28, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dimensional Fund Advisors LP. Shared-story counts are live from our verified record — not editorial picks.
Six major institutional investors have collectively added over 3.8 million AstraZeneca shares across recent quarters, signaling strong professional confidence in the company's diversified healthcare portfolio spanning oncology, cardiovascular, respiratory, and rare disease treatments. The sustained buying pattern highlights institutional conviction in AstraZeneca's ability to deliver innovative therapies that address critical unmet medical needs.
